Dowling JJ, Müller-Felber W, Smith BK, Bönnemann CG, Kuntz NL, Muntoni F, Servais L, Alfano LN, Beggs AH, Bilder DA, Blaschek A, Duong T, Graham RJ, Jain M, Lawlor MW, Lee J, Coats J, Lilien C, Lowes LP, MacBean V, Neuhaus S, Noursalehi M, Pitts T, Finlay C, Christensen S, Rafferty G, Seferian AM, Tsuchiya E, James ES, Miller W, Sepulveda B, Vila MC, Prasad S, Rico S, Shieh PB, INCEPTUS investigators. INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular Myopathy. J Neuromuscul Dis. 2022;9(4):503-516 PMID: 35694931 PMCID: PMC9398079 SCOPUS ID: 2-s2.0-85133659377 06/14/2022
Forseth B, Polfuss M, Brondino M, Hunter SD, Lawlor MW, Beatka MJ, Prom MJ, Eells J, Lyons JA. Adherence to and changes in mental and physiological health during an 8-week yoga intervention: A pilot study. J Bodyw Mov Ther. 2022 Apr;30:203-209 PMID: 35500972 SCOPUS ID: 2-s2.0-85126290657 05/03/2022
Forseth B, Polfuss M, Brondino M, Hunter SD, Lawlor MW, Beatka MJ, Prom MJ, Eells J, Lyons JA. Adherence to and changes in mental and physiological health during an 8-week yoga intervention: A pilot study Journal of Bodywork and Movement Therapies. April 2022;30:203-209 SCOPUS ID: 2-s2.0-85126290657 04/01/2022
Gartz M, Haberman M, Prom MJ, Beatka MJ, Strande JL, Lawlor MW. A Long-Term Study Evaluating the Effects of Nicorandil Treatment on Duchenne Muscular Dystrophy-Associated Cardiomyopathy in mdx Mice. J Cardiovasc Pharmacol Ther. 2022;27:10742484221088655 PMID: 35353647 SCOPUS ID: 2-s2.0-85127284016 03/31/2022
Eggers M, Vannoy CH, Huang J, Purushothaman P, Brassard J, Fonck C, Meng H, Prom MJ, Lawlor MW, Cunningham J, Sadhu C, Mavilio F. Muscle-directed gene therapy corrects Pompe disease and uncovers species-specific GAA immunogenicity EMBO Molecular Medicine. 11 January 2022;14(1) SCOPUS ID: 2-s2.0-85120325821 01/11/2022
Eggers M, Vannoy CH, Huang J, Purushothaman P, Brassard J, Fonck C, Meng H, Prom MJ, Lawlor MW, Cunningham J, Sadhu C, Mavilio F. Muscle-directed gene therapy corrects Pompe disease and uncovers species-specific GAA immunogenicity. EMBO Mol Med. 2022 Jan 11;14(1):e13968 PMID: 34850579 PMCID: PMC8749482 SCOPUS ID: 2-s2.0-85120325821 12/02/2021
Sullivan RT, Lam NT, Haberman M, Beatka MJ, Afzal MZ, Lawlor MW, Strande JL. Cardioprotective effect of nicorandil on isoproterenol induced cardiomyopathy in the Mdx mouse model BMC Cardiovascular Disorders. December 2021;21(1) SCOPUS ID: 2-s2.0-85107953538 12/01/2021
Hamm SE, Fathalikhani DD, Bukovec KE, Addington AK, Zhang H, Perry JB, McMillan RP, Lawlor MW, Prom MJ, Vanden Avond MA, Kumar SN, Coleman KE, Dupont JB, Mack DL, Brown DA, Morris CA, Gonzalez JP, Grange RW. Erratum: Voluntary wheel running complements microdystrophin gene therapy to improve muscle function in mdx mice. Mol Ther Methods Clin Dev. 2021 Dec 10;23:460 PMID: 34820472 PMCID: PMC8585580 11/26/2021
Lawlor MW, Dowling JJ. X-linked myotubular myopathy. Neuromuscul Disord. 2021 Oct;31(10):1004-1012 PMID: 34736623 SCOPUS ID: 2-s2.0-85118478299 11/06/2021
Li N, Parkes JE, Spathis R, Morales M, Mcdonald J, Kendra RM, Ott EM, Brown KJ, Lawlor MW, Nagaraju K. The Effect of Immunomodulatory Treatments on Anti-Dystrophin Immune Response After AAV Gene Therapy in Dystrophin Deficient mdx Mice. J Neuromuscul Dis. 2021;8(s2):S325-S340 PMID: 34569971 SCOPUS ID: 2-s2.0-85120957320 09/28/2021